Stryker Corp

$ 180.26 0.02 (0.01%)
Volume: 3,396,733 Avg Vol (1m): 1,218,107
Market Cap $: 67.26 Bil Enterprise Value $: 73.42 Bil
P/E (TTM): 19.30 P/B: 5.75
Earnings Power Value 57.73
Net Current Asset Value -15.4
Tangible Book -2.66
Projected FCF 74.34
Median P/S Value 119.29
Graham Number 0
Peter Lynch Value 77.71
DCF (FCF Based) 57.36
DCF (Earnings Based) 104.49
YTD (-%)

Financial Strength : 5/10

Current vs industry vs history
Cash-to-Debt 0.38
Equity-to-Asset 0.43
Debt-to-Equity 0.84
Debt-to-EBITDA 3.00
Piotroski F-Score 5
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 4.16
DISTRESS
GREY
SAFE
Beneish M-Score -2.25
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC 25.21%
WACC 7.84%

Profitability & Growth : 8/10

Current vs industry vs history
Operating Margin % 18.82
Net Margin % 26.12
ROE % 35.37
ROA % 15.42
ROC (Joel Greenblatt) % 54.05
3-Year Total Revenue Growth Rate 11.00
3-Year Total EBITDA Growth Rate 8.70
3-Year EPS w/o NRI Growth Rate 35.20

» SYK's 30-Y Financials

Financials (Next Earnings Date: 2019-04-23)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NYSE:SYK

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Medical Devices » Medical Devices    NAICS : 339112    SIC : 3841
Compare NAS:ISRG NYSE:BSX NYSE:EW NYSE:ZBH NYSE:ABT NAS:ALGN NYSE:MDT LSE:SN. NAS:ABMD NYSE:TFX XSWX:SOON NYSE:VAR SZSE:300003 OCSE:WDH XPAR:DIM ASX:COH LSE:CTEC NZSE:FPH NYSE:GMED OCSE:AMBU B
Traded in other countries 0R2S.UK
Address 2825 Airview Boulevard, Kalamazoo, MI, USA, 49002
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Approximately 35% of Stryker's total revenue currently comes from outside the United States.

Ratios

Current vs industry vs history
PE Ratio (TTM) 19.30
Forward PE Ratio 22.27
N/A
PE Ratio without NRI 19.30
Price-to-Owner-Earnings 18.65
PB Ratio 5.75
PS Ratio 5.04
Price-to-Free-Cash-Flow 33.63
Price-to-Operating-Cash-Flow 26.26
EV-to-EBIT 28.68
EV-to-EBITDA 22.36
EV-to-Revenue 5.40
PEG Ratio 2.14
Shiller PE Ratio 45.85
Current Ratio 2.02
Quick Ratio 1.41
Days Inventory 214.74
Days Sales Outstanding 62.58
Days Payable 50.57

Dividend & Buy Back

Current vs industry vs history
Dividend Yield % 1.10
Dividend Payout Ratio 0.21
3-Year Dividend Growth Rate (Per Share) 10.90
Forward Dividend Yield % 1.15
N/A
Yield-on-Cost (5-Year) % 1.90
3-Year Share Buyback Rate -0.10

Valuation & Return

Current vs industry vs history
Price-to-Projected-FCF 2.42
Price-to-DCF (Earnings Based) 1.73
Price-to-Median-PS-Value 1.51
Price-to-Peter-Lynch-Fair-Value 2.32
Earnings Yield (Joel Greenblatt) % 3.49
Forward Rate of Return (Yacktman) % 10.35

More Statistics

Revenue (TTM) (Mil) $ 13,601
EPS (TTM) $ 9.34
Beta 1.04
Volatility % 24.14
52-Week Range $ 144.75 - 199.85
Shares Outstanding (Mil) 373.11

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 5
Positive ROA Y
Positive CFROA Y
Higher ROA yoy Y
CFROA > ROA N
Lower Leverage yoy N
Higher Current Ratio yoy N
Less Shares Outstanding yoy Y
Higher Gross Margin yoy N
Higher Asset Turnover yoy Y